Fransien Van Hende

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

AZ Delta(Current)

Cliniques Universitaires Saint-Luc

AZ Turnhout

AZ Klina

AZ Groeninge

Fransien Van Hende is an author at AZ Delta specializing in metastatic disease treatment, metastatic castration-resistant prostate cancer, and oncology.

Publications per year

2016–2017

Publications

Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program

Charles Van Praet, Sylvie Rottey, Fransien Van Hende et al. · Urologic Oncology Seminars and Original Investigations · 2016 · 13 citations · Full text

Medicine, Oncology, Urology +16

Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?

Charles Van Praet, Sylvie Rottey, Fransien Van Hende et al. · Clinical Genitourinary Cancer · 2017 · 10 citations

Medicine, Oncology, Urology +16

1–2 of 2